so again, we. >> believe kagoshima. >> is well tolerated.ut tolerability is also a notion of how much weight. >> do you. >> lose and how. >> fast do you lose it. so i actually think that's a positive for kagoshima. >> so perhaps patients. >> were actually happy with how much weight they. >> had lost. >> yeah. >> when you if. >> you do. >> just the. >> math. >> if you for. >> instance start with a bmi. >> of 32, you lose 25% body. weight and you approach a body weight. >> of. >> you know, 25, then you're no longer considered obese. so when you deal with really potent. >> biologies like we. >> do with asthma, you'll see patients responding differently and some responding very, very significantly. and that's i think, a positive. >> you also. >> working on another drug called amikacin. >> explain to. >> us the strategy. >> here with grissom and amy creighton. >> yeah. >> so we. >> have all along. >> felt that. >> the two most powerful. >> biologies in weight loss is. >> glp. >> one and amylin, and that we now combine in different ways based on d